Compounds
US9090606B2 · kind B2 · utility
5Cited by
9References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2013 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | Dec 5, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D453/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) defined herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract characterized by airway obstruction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.